JRCT ID: jRCT2061240030
Registered date:04/07/2024
Use-result survey of GOBIK Aqueous Suspension Syringes
Basic Information
Recruitment status | Pending |
---|---|
Health condition(s) or Problem(s) studied | Prevention of pertussis,diphtheria,tetanus,poliomyelitis and invasive disease due to Hib infections |
Date of first enrollment | 22/07/2024 |
Target sample size | 1500 |
Countries of recruitment | |
Study type | Observational |
Intervention(s) |
Outcome(s)
Primary Outcome | safety:Rate of vaccine-related adverse event, Factors that may influence safety, Rate of serious vaccine-related adverse event |
---|---|
Secondary Outcome |
Key inclusion & exclusion criteria
Age minimum | >= 2month old |
---|---|
Age maximum | <= 15age old |
Gender | Both |
Include criteria | Children who have received the vaccine as primary immunization or booster immunization |
Exclude criteria | none |
Related Information
Primary Sponsor | Fujii Takeshi |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | |
Secondary ID(s) |
Contact
Public contact | |
Name | Takeshi Fujii |
Address | 4-1-70,SETO-CHO,KAN-ONJI,KAGAWA Kagawa Japan 768-0065 |
Telephone | +81-875-25-4835 |
gpsp@mail.biken.or.jp | |
Affiliation | The Research Foundation for Microbial Diseases of Osaka University |
Scientific contact | |
Name | Takeshi Fujii |
Address | 4-1-70,SETO-CHO,KAN-ONJI,KAGAWA Kagawa Japan 768-0065 |
Telephone | +81-875-25-4835 |
gpsp@mail.biken.or.jp | |
Affiliation | The Research Foundation for Microbial Diseases of Osaka University |